Daicel
4202.TTSE PRIMEChemicals
Financials · Consolidated
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥579.6bn | ¥586.5bn | ¥558.1bn | ¥538.0bn | ¥467.9bn | ¥393.6bn |
| Operating income | ¥42.1bn | ¥61.0bn | ¥62.4bn | ¥47.5bn | ¥50.7bn | ¥31.7bn |
| Ordinary income | ¥45.1bn | ¥62.3bn | ¥68.4bn | ¥52.0bn | ¥57.3bn | ¥34.7bn |
| Net income (owners) | ¥10.2bn | ¥49.5bn | ¥55.8bn | ¥40.7bn | ¥31.3bn | ¥19.7bn |
| Total assets | ¥833.9bn | ¥813.8bn | ¥839.2bn | ¥765.6bn | ¥698.8bn | ¥640.4bn |
| Net assets / equity | ¥370.4bn | ¥375.0bn | ¥375.4bnr | ¥310.4bn | ¥279.5bn | ¥245.0bn |
| Operating cash flow | ¥67.8bn | ¥93.4bn | ¥76.7bn | ¥26.8bn | ¥43.0bn | ¥57.9bn |
| EPS (basic) | ¥38.75 | ¥181.44 | ¥197.56 | ¥138.87 | ¥104.14 | ¥65.18 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 2
| Period | Form | Figures |
|---|---|---|
| 2025-04-01 → 2025-09-30 | Half-year | 71 figures · EDINET |
| 2024-04-01 → 2024-09-30 | Half-year | 71 figures · EDINET |
21 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| Engineering Plastics | ¥254.7bn | ¥19.2bn |
| Medical Healthcare | ¥16.2bn | ¥427m |
| Safety | ¥104.2bn | ¥6.1bn |
| Smart | ¥37.7bn | ¥536m |
| Other segments | ¥5.4bn | ¥904m |
| Adjustments & eliminations | — | — |
| Total | ¥574.2bn | ¥41.2bn |
| Total | ¥579.6bn | ¥42.1bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.